JPMORGAN CHASE & CO - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 70 filers reported holding RECRO PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q2 2021$297,000
+253.6%
128,440
+328.4%
0.00%
Q1 2021$84,000
+20.0%
29,981
+21.0%
0.00%
Q4 2020$70,000
+366.7%
24,769
+242.9%
0.00%
Q3 2020$15,000
-50.0%
7,224
+10.8%
0.00%
Q2 2020$30,000
-43.4%
6,518
+1.2%
0.00%
Q1 2020$53,000
-93.9%
6,441
-86.5%
0.00%
Q4 2019$875,000
-38.9%
47,771
-63.1%
0.00%
Q3 2019$1,433,000
-0.2%
129,361
-13.1%
0.00%
Q2 2019$1,436,000
+135.8%
148,946
+43.4%
0.00%
Q1 2019$609,000
-31.6%
103,862
-17.2%
0.00%
Q4 2018$891,000
+26.7%
125,500
+26.9%
0.00%
Q3 2018$703,000
+40.3%
98,898
-0.8%
0.00%
Q2 2018$501,000
-53.9%
99,696
+1.0%
0.00%
Q1 2018$1,087,000
+271.0%
98,751
+211.8%
0.00%
Q4 2017$293,000
+48.7%
31,673
+45.4%
0.00%
Q3 2017$197,000
+264.8%
21,784
+183.4%
0.00%
Q2 2017$54,000
+500.0%
7,686
+651.3%
0.00%
Q3 2016$9,0001,0230.00%
Other shareholders
RECRO PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 850,129$2,423,0000.65%
Newtyn Management, LLC 700,000$1,995,0000.46%
Portolan Capital Management 1,293,376$3,686,0000.34%
Rubric Capital Management LP 1,076,587$3,068,0000.22%
ESSEX INVESTMENT MANAGEMENT CO LLC 99,046$282,0000.04%
Alyeska Investment Group, L.P. 736,821$2,100,0000.03%
STEPHENS INC /AR/ 510,569$1,455,0000.03%
Clear Harbor Asset Management, LLC 46,682$133,0000.02%
WYNNEFIELD CAPITAL INC 13,000$37,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 451,301$1,286,0000.01%
View complete list of RECRO PHARMA INC shareholders